JABLX
Price
$53.08
Change
+$0.18 (+0.34%)
Updated
Jul 17 closing price
Net Assets
9.31B
RLBCX
Price
$36.65
Change
+$0.09 (+0.25%)
Updated
Jul 17 closing price
Net Assets
251.77B
Interact to see
Advertisement

JABLX vs RLBCX

Header iconJABLX vs RLBCX Comparison
Open Charts JABLX vs RLBCXBanner chart's image
Janus Henderson VIT Balanced Instl
Price$53.08
Change+$0.18 (+0.34%)
VolumeN/A
Net Assets9.31B
American Funds American Balanced R3
Price$36.65
Change+$0.09 (+0.25%)
VolumeN/A
Net Assets251.77B
JABLX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JABLX vs. RLBCX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JABLX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 252B vs. JABLX (9.31B). JABLX pays higher dividends than RLBCX: JABLX (2.03) vs RLBCX (1.57). JABLX was incepted earlier than RLBCX: JABLX (32 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than JABLX (0.62). JABLX is a more actively managed with annual turnover of: 83.00 vs. RLBCX (44.00). JABLX has a lower initial minimum investment than RLBCX: JABLX (0) vs RLBCX (250). JABLX annual gain was more profitable for investors over the last year : 7.82 vs. RLBCX (6.69). JABLX return over 5 years is better than : 45.49 vs. RLBCX (37.12).
JABLXRLBCXJABLX / RLBCX
Total Expense Ratio0.620.8970%
Annual Report Gross Expense Ratio0.620.8970%
Fund Existence32 years23 years-
Gain YTD4.3737.94655%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets9.31B252B4%
Annual Yield % from dividends2.031.57130%
Returns for 1 year7.826.69117%
Returns for 3 years38.7034.94111%
Returns for 5 years45.4937.12123%
Returns for 10 years104.7259.39176%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WINT1.050.15
+16.67%
Windtree Therapeutics Inc.
LOOP1.310.08
+6.50%
Loop Industries
STLD131.153.68
+2.89%
Steel Dynamics
TSHA2.590.05
+1.97%
Taysha Gene Therapies
ADNT22.05-0.33
-1.47%
Adient plc